Columbus McKinnon Declares Quarterly Dividend of $0.06 per Share
Get Alerts CMCO Hot Sheet
Join SI Premium – FREE
BUFFALO, N.Y.--(BUSINESS WIRE)-- Columbus McKinnon Corporation (Nasdaq: CMCO), a leading designer and manufacturer of motion control products, technologies, automated systems and services for material handling, today announced that its Board of Directors has approved payment of a regular quarterly dividend of $0.06 per common share.
The dividend will be payable on or about August 17, 2020 to shareholders of record at the close of business on August 7, 2020. Columbus McKinnon has approximately 23.8 million shares of common stock outstanding.
About Columbus McKinnon
Columbus McKinnon is a leading worldwide designer, manufacturer and marketer of motion control products, technologies and automated systems and services that efficiently and ergonomically move, lift, position and secure materials. Key products include hoists, crane components, actuators, rigging tools, light rail work stations, and digital power and motion control systems. The Company is focused on commercial and industrial applications that require the safety and quality provided by its superior design and engineering know-how. Comprehensive information on Columbus McKinnon is available at www.columbusmckinnon.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200720005634/en/
Gregory P. Rustowicz
Vice President - Finance and Chief Financial Officer
Columbus McKinnon Corporation
716-689-5442
[email protected]
Investor Relations:
Deborah K. Pawlowski
Kei Advisors LLC
716-843-3908
[email protected]
Source: Columbus McKinnon Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sygnia Reveals New Activity by China-Nexus Threat Actor Fire Ant Targeting Trusted Infrastructure
- Arrowhead Pharmaceuticals Presents Phase 3 SHASTA-3 and SHASTA-4 Data Demonstrating Plozasiran Reduced Acute Pancreatitis Events in Patients with Severe Hypertriglyceridemia
- Bayer Announces Phase III REVEAL Study with Investigational PET Radiotracer Iodine 124 Evuzamitide Presented as Late-Breaker at ESC 2026
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share